BSE filing, NSE: MAXIND. Summary written from the filing by ALFA Finder's alert engine.
Max India Ltd: key numbers
- Share price
- ₹150.89
- Market cap
- ₹849.8 Cr
- Revenue (annual)
- ₹190.6 Cr
- Net profit (annual)
- ₹-121.8 Cr
- P/E (TTM)
- -6.4×Sector 21.4×
- Promoter holding
- 48.22%-1.55% QoQ
- FII holding
- 6.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max India Ltd
All →Max India Business Update
Max India's subsidiary Antara Senior Care handed over 200 apartments at its Noida senior-living community. The milestone advances the 340-unit Phase 1 project in Sector 150, Noida.
Max India Other Announcement
Max India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory reporting requirements.
Max India Debt & Borrowing: ₹40 Cr
Max India executed a Letter of Comfort for Rs. 40 Crores in favor of Aditya Birla Capital Limited, supporting a credit facility for its subsidiary, Antara Senior Living.
- Value
- ₹40.00 Cr
Max India Partnership
Max India Foundation partnered with ISB to launch SCALE, a senior-care research initiative. Antara Senior Care joined as founding industry partner to advance evidence-based care.
Max India Annual General Meeting
Max India Limited concluded its 7th Annual General Meeting on August 19, 2026. Shareholders considered the adoption of FY26 financial statements and the re-appointment of Mr. Rajit Mehta.
Max India Earnings Call Transcript: Key Takeaways
Max India delivered a 66% YoY revenue jump to ₹68.6 Cr, yet remains loss-making with a ₹25 Cr EBITDA deficit, masked by optimistic real estate execution narratives.
- Call
- Guides 100% growth
Other board meeting date announcements
All →AGI Infra Board Meeting Date
AGI Infra will hold a board meeting on 6 November 2026 to approve unaudited standalone and consolidated results for Q2 and half-year. The trading window stays closed until 48 hours after the results are declared.
Fortis Healthcare Board Meeting Date
Fortis Healthcare will hold a board meeting on 5 November 2026 to approve Q2 and half-year unaudited results and alter terms of ₹1,550 Crore listed NCDs. The filing is a prior intimation of the board meeting with agenda items only.
Elfin Agro India Board Meeting Date
Elfin Agro India will hold a board meeting on 06 November 2026 to consider half-year unaudited results. The trading window remains closed until 48 hours after results.
Sigma Solve Board Meeting Date
SIGMA SOLVE LIMITED will hold a board meeting on 03 Nov 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. Investors should await the results filing.
Siddhi Cotspin Board Meeting Date
Siddhi Cotspin will hold a board meeting on 04-Nov-2026 to consider unaudited half-yearly results. Trading window closes until 07-11-2026.
Agarwal Fortune India Board Meeting Date
Agarwal Fortune India Ltd intimated BSE of a board meeting on 04 November 2026 to consider unaudited Q2 and half-year results ended September 30, 2026. The trading window stays closed until 06 November 2026.